Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Julianna Ianni, Vice President, AI Research & Development, Proscia – Interview Series

Proscia
By Author Proscia | March 17, 2021

Dr. Julianna Ianni, Vice President of AI Research and Development, recently sat down with Unite.AI for an interview on the growing impact of AI in pathology and Proscia’s focus on delivering computational applications that work in the “real world.” Read on as she explores key considerations in designing and developing DermAI, which classifies images of skin biopsies displaying more than 200 diagnoses with a high degree of accuracy, and unpacks the findings of our DermAI validation study – one of pathology’s most comprehensive to date.

Our website uses cookies. By using this site, you agree to its use of cookies.